BridgeBio Pharma Inc <BBIO.O>: Morgan Stanley cuts target price to $97.00 from $98.00
BBIO•Related News
Tripadvisor partners with Airbnb to offer select tours and activities for booking on platform
TRIP•
CPP Investments, ReNew founder Sumant Sinha lift buyout offer for ReNew to USD 7.02 per share
RNW•
Strategy schedules live investor Q&A featuring Michael Saylor, CEO Phong Le
MSTR•
Haleon launches USD senior notes offering alongside tender for USD 2 billion debt due 2027
HLN•
French press body asks competition watchdog to take action over Google AI
GOOGL•